论文部分内容阅读
GMP改造被称为是药品生产企业的生命工程。从SFDA获悉,截至2004年底,全国5071家药品生产企业中,已有3731家通过GMP认证,未通过认证的1340家企业已全部停产。GMP认证后,进一步增强了企业的质量意识,产品抽样检查合格率逐年上升,也在一定程度上抑制了产品的低水平重复。但是,在经历了GMP改造这道生死线之后,许多企业的众多棘手问题也便暴露无遗……同样,在经历了这场企业“大洗牌”的冲击后,济南药企又将何去何从呢?GMP的硝烟是否已完全消散? 就此,记者走近并采访了他们……
GMP transformation is known as the life engineering of pharmaceutical manufacturing enterprises. According to SFDA, as of the end of 2004, out of 5,071 drug manufacturers nationwide, 3,731 were GMP-certified, and 1,340 unqualified enterprises have all been discontinued. GMP certification, and further enhance the awareness of the quality of enterprises, product sampling pass rate increased year by year, but also to some extent, inhibit the low level of product duplication. However, after experiencing the GMP transformation of this life and death line, many of the many thorny issues of enterprises will be exposed ... Similarly, after experiencing the impact of this enterprise “big shuffle”, Jinan pharmaceutical companies will go from here? GMP smoke has completely dissipated? In this regard, the reporter approached and interviewed them ...